Rapid Generation of Functional Oligodendrocytes From Human Induced Pluripotent Stem Cells Through Small Molecule Guided Differentiation.
TL;DR
This study establishes a cost- and time-efficient approach for generating functional OLs from iPSCs, with broad applicability for disease modeling, drug screening, and the development of regenerative therapies.
Abstract
Oligodendrocytes (OLs) are essential for central nervous system (CNS) function through their role in axon myelination, and their dysfunction is implicated in a range of neurological disorders. Despite this, in vitro modeling of human OL biology remains limited by the scarcity of primary human OLs. Furthermore, while induced pluripotent stem cells (iPSCs) offer a promising source of human OLs, current differentiation protocols remain complex, inefficient, and time-consuming. Here, we present an optimized protocol to generate OLs from iPSCs (iOLs) using defined soluble factors supplemented in the culture media. Within 28 days, cultures yielded an average of 85% O4+ iOLs, and by Day 38, approximately 70% expressed MBP, a key marker of mature OLs. Bulk RNA-seq analysis confirmed a stepwise transcriptional progression consistent with OL lineage identity, with upregulation of key OL-specific transcripts and gene expression profiles. Comparative transcriptomic analyses further revealed increased expression of gene networks associated with myelination, extracellular matrix remodeling, and gliogenesis when iOLs were cultured on aligned nanofiber scaffolds. Importantly, iOLs formed compact myelin sheaths around axons and showed enhanced maturation in a three-dimensional (3D) environment, highlighting the importance of spatial and matrix-derived cues in OL development. This study establishes a cost- and time-efficient approach for generating functional OLs from iPSCs, with broad applicability for disease modeling, drug screening, and the development of regenerative therapies.